| ID | 1714 |
| No | 1714 |
| Brand Name | LUCIDELA |
| Ingredients | IDELALISIB 150 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 60'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF PATIENTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA, IN COMBINATION WITH RITUXIMAB, IN PATIENTS FOR WHOM RITUXIMAB ALONE WOULD BE CONSIDERD APPROPRIATE THERAPY DUE TO OTHER CO-MORBIDITIES |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | PINK COLOR TABLET |
| Note | |
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 03 L 1312/25 |
| FDD Registration Date | 07/04/2025 |
| Expiry Date | 06/04/2030 |